Page 1 - Drug Class Review
P. 1
Drug Class Review
on
Alzheimer’s Drugs
Final Report
June 2006
The purpose of this report is to make available information regarding the
comparative effectiveness and safety profiles of different drugs within
pharmaceutical classes. Reports are not usage guidelines, nor should they be
read as an endorsement of, or recommendation for, any particular drug, use or
approach. Oregon Health & Science University does not recommend or endorse
any guideline or recommendation developed by users of these reports.
Richard A. Hansen, Ph.D.
Gerald Gartlehner, M.D., M.P.H.
Daniel J. Kaufer M.D.
Kathleen N. Lohr, Ph.D.
Tim Carey, M.D., M.P.H.
RTI-UNC Evidence-based Practice Center
Cecil G. Sheps Center for Health Services Research
University of North Carolina at Chapel Hill
725 Airport Road, CB# 7590
Chapel Hill, NC 27599-7590
Tim Carey, M.D., M.P.H., Director
Oregon Evidence-based Practice Center
Oregon Health & Sciences University
Mark Helfand, MD, MPH, Director
Copyright © 2006 by Oregon Health & Science University
Portland, Oregon 97201. All rights reserved
